How should I treat an acute asthma exacerbation, including initial therapy, discharge criteria, and next-step options?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Asthma Exacerbation

Immediately administer high-flow oxygen (40-60%), nebulized salbutamol 5-10 mg, and systemic corticosteroids (prednisolone 30-60 mg orally or hydrocortisone 200 mg IV) to all patients with acute severe asthma, as CO2 retention is not aggravated by oxygen therapy in asthma and delay can be fatal. 1, 2

Initial Assessment and Severity Classification

Assess severity objectively using peak expiratory flow (PEF) and clinical parameters, as physician subjective assessments are often inaccurate 3:

Acute Severe Asthma:

  • PEF <50% predicted or best 1
  • Respirations ≥25 breaths/min 1
  • Pulse ≥110 beats/min 1
  • Inability to complete sentences 1

Life-Threatening Features (requiring immediate ICU consideration):

  • PEF <33% predicted 1, 2
  • Silent chest, cyanosis, or feeble respiratory effort 1, 2
  • Hypercapnia (PaCO2 >45 mmHg), respiratory acidosis, or severe hypoxemia 2
  • Exhaustion, confusion, altered consciousness, or bradycardia 1, 2

Immediate Treatment Protocol

First-Line Therapy (administer simultaneously):

Oxygen:

  • Deliver 40-60% oxygen via high-flow face mask to maintain SpO2 >92% 1, 4, 2
  • Never withhold oxygen due to hypercapnia concerns—this is a critical pitfall unique to asthma (unlike COPD) 2

Bronchodilators:

  • Nebulized salbutamol 5-10 mg (or terbutaline 5-10 mg) via oxygen-driven nebulizer 1, 2
  • Repeat every 15-30 minutes if no improvement 1

Systemic Corticosteroids:

  • Prednisolone 30-60 mg orally OR hydrocortisone 200 mg IV 1
  • Administer immediately without waiting for investigations, as clinical benefits require 6-12 hours to manifest 3
  • Underuse of corticosteroids is a major factor in preventable asthma deaths 5

Monitoring:

  • Repeat PEF measurement 15-30 minutes after starting treatment 1, 4
  • Continuous pulse oximetry maintaining SpO2 >92% 1, 4
  • Obtain chest radiograph to exclude pneumothorax 1

Escalation for Non-Responders (15-30 minutes)

If patient shows no improvement after initial therapy:

  • Continue oxygen and systemic steroids 1
  • Increase nebulized β-agonist frequency to every 15-30 minutes 1, 4
  • Add ipratropium 0.5 mg to nebulizer, repeat every 6 hours 1, 4
  • Repeat blood gas within 2 hours if initial PaO2 <60 mmHg or PaCO2 was normal/elevated 1, 2

For Life-Threatening Features:

  • Transfer to ICU immediately with physician prepared to intubate 2
  • Consider IV aminophylline 5 mg/kg over 20 minutes, then 1 mg/kg/hour maintenance (omit loading dose if already on oral theophyllines) 4

ICU Transfer Criteria

Transfer accompanied by physician prepared to intubate if: 1, 2

  • Deteriorating PEF despite treatment
  • Worsening or persistent hypoxia/hypercapnia
  • Exhaustion, feeble respirations, confusion, drowsiness, or coma
  • Respiratory arrest

Discharge Criteria

Patients must meet ALL of the following before discharge: 1, 5

  • On discharge medications for ≥24 hours 1, 5
  • PEF >75% predicted or personal best with <25% diurnal variability 1, 5
  • Inhaler technique checked and documented 1, 5
  • Written self-management plan provided 1, 5

Discharge Medications:

  • Oral prednisolone 30-60 mg daily for 3-10 days (no taper needed if <10 days) 5
  • Inhaled corticosteroids at higher dose than pre-admission 5
  • Bronchodilators (inhaled β-agonists) 1
  • Own peak flow meter 1

Mandatory Follow-Up:

  • Primary care within 1 week (ideally within 48 hours) 1, 5
  • Respiratory clinic within 4 weeks 1

Critical Pitfalls to Avoid

  • Never administer sedatives—they are absolutely contraindicated in acute severe asthma 2
  • Never withhold oxygen due to hypercapnia concerns (this applies to COPD, not asthma) 2
  • Never delay corticosteroids for investigations—administer immediately 4, 3
  • Never underestimate severity based on subjective assessment—use objective PEF measurements 3
  • Never discharge without written instructions—this significantly increases relapse risk 5
  • Never rely solely on inhaler therapy in acute severe asthma—failure to respond is a red flag requiring escalation 4

Pediatric Considerations

Acute Severe Asthma Recognition in Children: 1, 4

  • Too breathless to talk or feed
  • Respirations >50 breaths/min
  • Pulse >140 beats/min
  • PEF <50% predicted

Immediate Treatment: 1, 4

  • High-flow oxygen via face mask (maintain SpO2 >92%)
  • Nebulized salbutamol 2.5-5 mg (half dose in very young children)
  • IV hydrocortisone immediately
  • Add ipratropium 100 mcg nebulized every 6 hours

Discharge Steroid Regimen: 5

  • Prednisolone 1-2 mg/kg/day (maximum 60 mg/day) for 3-10 days
  • No taper needed if course <10 days
  • Initiate inhaled corticosteroids at higher dose than pre-admission

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Life-Threatening Asthma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chapter 14: Acute severe asthma (status asthmaticus).

Allergy and asthma proceedings, 2012

Guideline

Acute Severe Asthma Management in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Steroid Treatment for Discharge of an Asthmatic Child

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.